Navigation Links
Why can Buyang Huanwu Decoction be used to treat stroke?

The traditional Chinese medicine Buyang Huanwu Decoction has been shown to improve the neurological function of patients with stroke. Baiyan Liu from Hunan University of Traditional Chinese Medicine, China showed that Buyang Huanwu Decoction significantly increased the number of cells positive for 5-bromodeoxyuridine, a cell proliferation-related marker, microtubule-associated protein-2, a marker of neuronal differentiation, and growth-associated protein 43, a marker of synaptic plasticity in the ischemic rat cerebral regions. The number of positive cells peaked at 14 and 28 days after intragastric administration of Buyang Huanwu Decoction. These findings, published in the Neural Regeneration Research (Vol. 8, No. 25, 2013), suggest that Buyang Huanwu Decoction can promote the proliferation and differentiation of neural stem cells and enhance synaptic plasticity in ischemic rat brain tissue.


Contact: Meng Zhao
Neural Regeneration Research

Page: 1

Related biology news :

1. Ozone treated water v. lethal microbial material
2. Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
3. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
4. Genetic research develops tools for studying diseases, improving regenerative treatment
5. Step forward in research into new treatments for brain edema
6. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
7. New hope for treating Alzheimers Disease: A role for the FKBP52 protein
8. Marshall University study may lead to new treatments for prostate cancer
9. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
10. Discovery offers insight into treating viral stomach flu
11. Minimally invasive treatment for ruptured aneurysm: Safe, reduces mortality
Post Your Comments:
Related Image:
Why can Buyang Huanwu Decoction be used to treat stroke?
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: ... to provide their customers enhanced security to access ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
Breaking Biology Technology: